Thrombopénie immunologique : de la physiopathologie aux traitements
- 30 July 2020
- journal article
- review article
- Published by Elsevier BV in La Revue de Médecine Interne
- Vol. 42 (1), 16-24
- https://doi.org/10.1016/j.revmed.2020.06.020
Abstract
No abstract availableKeywords
This publication has 68 references indexed in Scilit:
- B cell depletion in immune thrombocytopenia reveals splenic long-lived plasma cellsJCI Insight, 2012
- Immunologic effects of rituximab on the human spleen in immune thrombocytopeniaBlood, 2011
- Improved regulatory T-cell activity in patients with chronic immune thrombocytopenia treated with thrombopoietic agentsBlood, 2010
- Complement activation on platelets correlates with a decrease in circulating immature platelets in patients with immune thrombocytopenic purpuraBritish Journal of Haematology, 2010
- Elevated profile of Th17, Th1 and Tc1 cells in patients with immune thrombocytopenic purpuraHaematologica, 2009
- Reduced Cd4+Cd25+ T cells in patients with idiopathic thrombocytopenic purpuraThrombosis Research, 2007
- FcRn: the neonatal Fc receptor comes of ageNature Reviews Immunology, 2007
- T-cell-mediated cytotoxicity toward platelets in chronic idiopathic thrombocytopenic purpuraNature Medicine, 2003
- The site of destruction of autologous 111In‐labelled platelets and the efficiency of splenectomy in children and adults with idiopathic thrombocytopenic purpura: a study of 578 patients with 268 splenectomiesBritish Journal of Haematology, 1997
- Dapsone for chronic autoimmune thrombocytopenic purpura: a report of 66 casesBritish Journal of Haematology, 1997